AMG 369 - CAS 1202073-26-4
Catalog number: 1202073-26-4
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C26H22FN3O2S
Molecular Weight:
459.54
COA:
Inquire
Targets:
Sphingosine 1 Phosphate Receptor
Description:
This active molecular is a S1P1/S1P5 agonist with limited activity at S1P3. AMG 369 has no activity at S1P2 and S1P4. AMG-369 is shown to reduce blood lymphocyte counts 24 hours postdose with dosed orally at 0.1 mg/kg. Till Jun 2016, no recent reports of development identified for preclinical development in Multiple-sclerosis in USA were published yet.
Purity:
98%
Appearance:
Powder
Synonyms:
AMG-369; AMG 369; AMG369; KB-74649; KB74649; KB 74649. 1-[[3-fluoro-4-[6-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylicacid; ZINC216149127;1202073-26-4
Solubility:
Soluble in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
Multiple sclerosis
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
InChIKey:
DSAOIEDPZKHAOM-UHFFFAOYSA-N
InChI:
InChI=1S/C26H22FN3O2S/c27-21-10-16(13-30-14-17(15-30)25(31)32)6-7-20(21)23-29-22-11-19(12-28-24(22)33-23)26(8-9-26)18-4-2-1-3-5-18/h1-7,10-12,17H,8-9,13-15H2,(H,31,32)
Canonical SMILES:
C1CC1(C2=CC=CC=C2)C3=CC4=C(N=C3)SC(=N4)C5=C(C=C(C=C5)CN6CC(C6)C(=O)O)F
Current Developer:
Amgen
1.Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5.
Cee VJ1, Frohn M1, Lanman BA1, Golden J1, Muller K1, Neira S1, Pickrell A1, Arnett H2, Buys J1, Gore A1, Fiorino M1, Horner M1, Itano A1, Lee MR1, McElvain M1, Middleton S1, Schrag M1, Rivenzon-Segal D3, Vargas HM1, Xu H1, Xu Y1, Zhang X1, Siu J1, Wong M1 ACS Med Chem Lett. 2010 Dec 29;2(2):107-12. doi: 10.1021/ml100306h. eCollection 2011.
The optimization of a series of thiazolopyridine S1P1 agonists with limited activity at the S1P3 receptor is reported. These efforts resulted in the discovery of 1-(3-fluoro-4-(5-(1-phenylcyclopropyl)thiazolo-[5,4-b]pyridin-2-yl)benzyl)azetidine-3-carboxylic acid (5d, AMG 369), a potent dual S1P1/S1P5 agonist with limited activity at S1P3 and no activity at S1P2/S1P4. Dosed orally at 0.1 mg/kg, 5d is shown to reduce blood lymphocyte counts 24 h postdose and delay the onset and reduce the severity of experimental autoimmune encephalomyelitis in rat.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Sphingosine 1 Phosphate Receptor Products


CAS 1355026-60-6 CYM 50260

CYM 50260
(CAS: 1355026-60-6)

CYM 50260 has been found to be a S1P4 agonist.

CAS 1345858-76-5 CYM 50308

CYM 50308
(CAS: 1345858-76-5)

CYM 50308 has been found to be an effective and selective S1P4 agonist.

CYM 50358 hydrochloride

The hydrochloride salt form of CYM 50358, which has been found to be an effective S1P4 antagonist.

CAS 1306760-87-1 Ozanimod

Ozanimod
(CAS: 1306760-87-1)

Ozanimod, also known as RPC1063, is a selective oral S1P Receptor 1 modulator.

CAS 1202073-26-4 AMG 369

AMG 369
(CAS: 1202073-26-4)

This active molecular is a S1P1/S1P5 agonist with limited activity at S1P3. AMG 369 has no activity at S1P2 and S1P4. AMG-369 is shown to reduce blood lymphocyt...

CAS 547756-93-4 JTE 013

JTE 013
(CAS: 547756-93-4)

JTE 013 has been found to be an antagonist of Sphingosine-1-Phosphate Receptor-2 (S1P2R).

CAS 840523-39-9 CS-0777-P

CS-0777-P
(CAS: 840523-39-9)

CS-0777 is a selective sphingosine 1-phosphate receptor modulator agonist. It is in clinical trials for the treatment of multiple sclerosis, but no recent devel...

PF-543 hydrochloride
(CAS: 1706522-79-3)

The hydrochloride salt form of PF-543, a novel SphK1 inhibitor that could exhibit activity in induceing necrosis in human colorectal cancer cells in biological ...

Chemical Structure

CAS 1202073-26-4 AMG 369

Quick Inquiry

Verification code

Featured Items